Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients

BACKGROUND: The immune checkpoint of programmed cell death ligand 1 (PD-L1) commonly expressed in solid cancers, and the blockade of this molecule show promising results in advanced cancers, including lung cancer. The relevance of PD-L1 to patient-derived xenograft (PDX) formation and clinicopatholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yuanyuan, Zhang, Panpan, An, Guo, Zhang, Xiaolong, Zhang, Liyi, Si, Jiahui, Zhang, Jianzhi, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087670/
https://www.ncbi.nlm.nih.gov/pubmed/27784882
http://dx.doi.org/10.12659/MSM.900661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087670/
https://www.ncbi.nlm.nih.gov/pubmed/27784882
http://dx.doi.org/10.12659/MSM.900661

Ejemplares similares